Safety Study of CX11 Tablets for Weight Management
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether a new medication called CX11 is safe and well-tolerated at different doses in people with overweight or obesity. The goal is to understand how the body responds to the drug before larger trials test whether it helps with weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–55 years old
- Overweight or obese (BMI of 30 or higher, or 27–30 with a weight-related health condition like prediabetes, high blood pressure, high cholesterol, or sleep apnea)
- Stable weight for at least 90 days and history of unsuccessful diet or exercise attempts
- No recent weight-loss medications, GLP-1 drugs (like Ozempic or Wegovy), or weight-loss surgery
- No personal or family history of medullary thyroid cancer or multiple endocrine neoplasia
- Able to follow study procedures and agree to reproductive safety requirements
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medication called ERX1000 is safe and well-tolerated in adults with obesity. The trial will help doctors understand if this treatment could be helpful for weight management.
This study tests a new approach to help with weight loss and body fat reduction. It may be a good fit if you are an adult with a BMI in the overweight to moderately obese range and you are not currently using weight-loss medications.
This study tests a new medication called CMS-D008 to see if it can help with weight loss in overweight or obese adults. It is an early-stage trial, so the main goals are to check safety and how the body handles the drug.
This study tests an investigational medication called MBX 4291 for adults with obesity. It aims to see if the drug is safe and how it works in the body, which could lead to a new weight-loss treatment option.
This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.
This study tests a new medicine (PF-08653944) for weight loss in Chinese adults who are overweight or have obesity. It aims to see if the medicine is safe and how it works in the body.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.